Skip to main content
Skip to main content
Home
Company
About Us
Executive Team
Board of Directors
Scientific & Clinical Advisors
Partners
Pipeline
Technology
EQ504
EQ302
Publications
Presentations
Investors
Investor Overview
Stock Information
Stock Chart
Analyst Coverage
Press Releases
Events & Presentations
Email Alerts & Contacts
SEC Filings
Corporate Governance
Governance Documents
Committee Composition
Investor FAQs
Careers
Contact Us
Search query
Presentation Details
Back
EQ504, a Potent AhR Modulator, Promotes Epithelial Repair and Barrier Restoration Compared to Clinically Validated AhR Agonists<span>Mary Casis, et al.</span><span> American Association of Immunology Conference </span><span>2026</span>
04/20/2026
Download this Press Release
PDF Format (opens in new window)
Mary Casis, et al.
Conference:
American Association of Immunology Conference
Year:
2026
